FULCRUM THERAPEUTICS, INC. Payments for Operating Activities
FULCRUM THERAPEUTICS, INC. (FULC) reported Payments for Operating Activities of $427.00 thousand for the 12-month period ending 2022-12-31, per its 10-K/A filed 2023-06-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:PaymentsForOperatingActivities · last filed 2023-06-26
- FULCRUM THERAPEUTICS, INC. payments for operating activities for the quarter ending 2022-12-31 was $16.00K.
- FULCRUM THERAPEUTICS, INC. payments for operating activities for fiscal 2022 was $427.00K.
| Period end | Payments for Operating Activities 3 month | Payments for Operating Activities 9 month | Payments for Operating Activities 12 month |
|---|---|---|---|
| 2022-12-31 | $16.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-26 | $427.00K 10-K/A · filed 2023-06-26 | |
| 2022-09-30 | $411.00K 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |